Latest National Cancer Institute Stories
A new public-private partnership is committing $11.5 million towards transformational, theoretical biophysics that could have a significant impact on cancer research and treatment.
In the news release, Oncolytics Biotech® Inc. Announces Completion of Patient Enrollment in U.S.
The anti-cancer drug Xalkori® is being investigated by the ECOG-ACRIN Cancer Research Group in E4512, a phase III trial. Philadelphia, PA (PRWEB) August
TORONTO, ON and CHICAGO, IL, Aug. 11, 2014 /PRNewswire/ - Concordia Healthcare Corp.
By the National Cancer Institute BETHESDA, Md., Aug.
The Mesothelioma Victims Center is releasing new information this week on where to find the most current and up-to-date news on treatment options from organizations such as the National Cancer
Discovery Accepted into NCI Drug Development Program for Clinical Trials Philadelphia, PA (PRWEB) July 28, 2014 An estimated 68,000 women and men in
CALGARY, July 8, 2014 /PRNewswire/ - Oncolytics Biotech Inc.
- A person in a secondary role, specifically the second most important character (after the protagonist).